2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
The duplicated region <strong>of</strong> the PKD1 gene was amplified by long range<br />
polymerase chain reaction (PCR) followed by nested PCR . Mutation<br />
screening was performed using denaturing gradient gel electrophoresis<br />
(DGGE), heteroduplex analysis (HA) and high-resolution melting<br />
(HRM) . Suspected samples were then sequenced .<br />
In the PKD1 gene we detected 30 germline mutations among 90 unrelated<br />
individuals; 24 mutations unique for Czech population . We identified<br />
11 nonsense mutations, 13 missense mutations, 3 frameshifting<br />
mutations, 2 deletion in-frame and 1 mutation in splice site . In the<br />
PKD1 gene we detected great numbers <strong>of</strong> different polymorphisms or<br />
unclassified variants.<br />
Establishment <strong>of</strong> localisation and type <strong>of</strong> mutations and their genotype<br />
- phenotype correlation in ADPKD families will improve DNA diagnosis<br />
and could help to assess the clinical prognosis <strong>of</strong> ADPKD patients .<br />
Supported by grant projects IGA MZ CR NR/9427-3, VZ MSMT<br />
0021620806<br />
P06.235<br />
the association <strong>of</strong> metabotropic glutamate receptor subtype 8<br />
(mGluR8) polymorphism with executive attention<br />
J. V. Schegolkova, V. A. Shleptsova, A. G. Tonevitsky;<br />
Moscow State University, Moscow, Russian Federation.<br />
The glutamatergic signaling pathway represents candidate susceptibility<br />
system involved in mechanism <strong>of</strong> forming attention and working<br />
capacity . One <strong>of</strong> attractive candidate for study <strong>of</strong> molecular physiology<br />
<strong>of</strong> attention is metabotropic glutamate receptor subtype 8 (mGluR8) .<br />
Expression <strong>of</strong> mGluR8 was observed in the olfactory system, the neocortex,<br />
the limbic cortex including the hippocampus and the amygdala .<br />
Electron microscopically, mGluR8 was largely observed on the axon<br />
terminals . Especially in several regions <strong>of</strong> the hippocampus it was<br />
found in the active zone <strong>of</strong> both asymmetrical and symmetrical synapses<br />
where mGluR8 may regulate glutamate release as an autoreceptor<br />
or GABA release heterosynaptically .<br />
Influence <strong>of</strong> mGluR8 polymorphism located 29 bp after the termination<br />
codon (2756C/T) on executive attention was conducted on volunteers<br />
. 108 students <strong>of</strong> Moscow State University (mean age 20±2, girls<br />
= 61, boys = 47) were tested by Schulte tables. We found significant<br />
association <strong>of</strong> mGluR8 polymorphism with executive attention only in<br />
males . Carriers <strong>of</strong> T allele (TT,CT) implemented the test faster than CC<br />
group (p=0,02) .<br />
P06.236<br />
Q192R and L55m polymorphism <strong>of</strong> PON1 in patients with<br />
coronary heart disease (cHD) <strong>of</strong> different age and sex.<br />
G. D. Pardo Perales 1 , M. A. Bogdanova 2 , A. N. Voitovich 2 , O. S. Romashkina 2 ,<br />
O. A. Bercovich 3 , S. I. Yagashkina 4 , O. N. Semenova 4 , V. A. Isakov 2 , O. A.<br />
Berkovich 5 , H. B. Kirillova 1 , V. I. Larionova 2 ;<br />
1 St. Petersburg State Chemical Pharmaceutical Academy, Saint-Petersburg,<br />
Russian Federation, 2 St. Petersburg State Pediatric Medical Academy, Saint-<br />
Petersburg, Russian Federation, 3 St. Petersburg Electrotechnical University,<br />
Russia, Saint-Petersburg, Russian Federation, 4 Research Center for people<br />
who lived in blockaded Leningrad, Saint-Petersburg, Russian Federation, 5 St.<br />
Petersburg State Medical University, Saint-Petersburg, Russian Federation.<br />
Paraoxonase-1, a high-density lipoprotein-associated enzyme, is<br />
believed to protect low-density lipoproteins from oxidation and thus<br />
decrease the risk <strong>of</strong> CHD . The aim <strong>of</strong> this study was to investigate if<br />
paraoxonase-1 gene (PON1) Q192R and L55M polymorphisms influence<br />
the risk <strong>of</strong> CHD . 597 patients (438 men and 159 women) were<br />
included in our study: 227 men who survived myocardial infarction (MI)<br />
under the age <strong>of</strong> 45 (group I), 96 men with MI after 60 years (group II)<br />
and 115 healthy men (group III); 75 angiographicaly diagnosed CHD<br />
women (group IV) and 84 women without CHD (group V) . All patients<br />
originated from Saint-Petersburg, Russia . Genotypes were determined<br />
by PCR-RFLP, paraoxonase activities were measured spectrophotometrically<br />
and standard enzymatic methods were used to determine<br />
levels <strong>of</strong> total cholesterol, triglycerides and HDL cholesterol on a spectrum<br />
analyzer. Statistical significance <strong>of</strong> differences between groups<br />
was assessed with χ 2 -test . We found that in group IV the frequency<br />
<strong>of</strong> 55M allele <strong>of</strong> PON1 was a statistically higher comparing to group V<br />
(p=0,029). In group I amount <strong>of</strong> QR patients were significantly higher<br />
comparing to group IV (p=0,003) . In group II amount <strong>of</strong> QQ patients<br />
were significantly lower comparing to group IV (p=0,009). There were<br />
no any differences in allele or genotype frequencies distributions be-<br />
tween the groups <strong>of</strong> CHD men . Our results suggest that both Q192R<br />
and L55M PON1 polymorphisms play the role in risk <strong>of</strong> CHD . Furthermore,<br />
PON1 polymorphisms act in various ways in patients <strong>of</strong> different<br />
age and sex .<br />
P06.237<br />
the associations between PON1 55mm genotype and coronary<br />
artery disease and between the low HDL/LDL ratio values and<br />
the large arteries diseases<br />
E. Strauss 1 , K. Waliszewski 2 , W. Supinski 3 , J. Gluszek 2 , W. Majewski 2 , M.<br />
Swierczek 1 , M. Juszczak 1 , A. L. Pawlak 1 ;<br />
1 Institute <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, Polish Academy <strong>of</strong> Sciences, Poznan, Poland,<br />
2 Medical University, Poznan, Poland, 3 Regional Hospital, Gorzow Wkp, Poland.<br />
The differences in the vascular diseases risk factor pr<strong>of</strong>iles, depending<br />
on the localization <strong>of</strong> the arterial diseases were analyzed in the series<br />
<strong>of</strong> 428 patients with coronary artery disease (CAD), 210 patients with<br />
aortoiliac occlusive disease (AIOD) and 255 cases <strong>of</strong> abdominal aortic<br />
aneurysm (AAA) - total 893 <strong>of</strong> vascular disease patients, as well as<br />
in 262 persons without symptoms <strong>of</strong> vascular disease . The SNPs <strong>of</strong><br />
the genes related to the homocysteine metabolism: MTHFR 677 C>T,<br />
PON1-108C>T, L55M; as well as the lipoprotein pr<strong>of</strong>iles were analyzed<br />
in search for the functional differences predisposing either to the CAD<br />
or to the diseases <strong>of</strong> the large arteries . The SNPs were determined by<br />
PCR-RLFP methods .<br />
In CAD group frequency <strong>of</strong> PON1 55MM genotypes (16,6%) was<br />
about 1,7-fold higher as compared to this either in AIOD+AAA group<br />
(10,8%, p